🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/2014 | 56,11 | 56,17 | 55,68 | 55,74 | -0,32% | 0,88% | 9.897.207 |
| 15/08/2014 | 56,11 | 56,30 | 55,37 | 55,93 | -0,29% | 1,65% | 9.481.046 |
| 14/08/2014 | 55,39 | 56,10 | 55,34 | 56,09 | +1,61% | 1,36% | 8.313.050 |
| 13/08/2014 | 54,76 | 55,24 | 54,54 | 55,20 | +1,44% | 1,27% | 11.172.414 |
| 12/08/2014 | 53,96 | 54,52 | 53,93 | 54,42 | +0,65% | 1,10% | 7.430.530 |
| 11/08/2014 | 54,10 | 54,44 | 53,87 | 54,06 | +0,19% | 1,04% | 5.763.057 |
| 08/08/2014 | 53,31 | 54,02 | 53,03 | 53,96 | +1,64% | 1,84% | 7.421.412 |
| 07/08/2014 | 53,64 | 53,97 | 53,02 | 53,09 | -0,52% | 1,76% | 7.561.844 |
| 06/08/2014 | 53,32 | 53,57 | 53,17 | 53,37 | -0,18% | 0,75% | 12.865.038 |
| 05/08/2014 | 54,12 | 54,36 | 53,26 | 53,46 | -1,81% | 2,03% | 9.464.698 |
| 04/08/2014 | 54,34 | 54,65 | 53,78 | 54,45 | +0,46% | 1,60% | 9.064.676 |
| 01/08/2014 | 53,99 | 54,50 | 53,70 | 54,20 | +0,11% | 1,48% | 10.627.768 |
| 31/07/2014 | 55,11 | 55,41 | 54,12 | 54,14 | -2,31% | 2,34% | 10.604.712 |
| 30/07/2014 | 55,90 | 56,15 | 54,97 | 55,42 | -0,85% | 2,12% | 8.438.286 |
| 29/07/2014 | 56,13 | 56,56 | 55,48 | 55,90 | +1,05% | 1,94% | 10.823.744 |
| 28/07/2014 | 55,51 | 55,67 | 55,20 | 55,31 | -0,31% | 0,84% | 9.013.534 |
| 25/07/2014 | 55,47 | 55,69 | 55,27 | 55,49 | -0,10% | 0,76% | 5.790.305 |
| 24/07/2014 | 55,65 | 55,82 | 55,27 | 55,54 | +0,17% | 0,99% | 10.547.282 |
| 23/07/2014 | 55,63 | 55,82 | 55,39 | 55,45 | -0,55% | 0,77% | 6.594.435 |
| 22/07/2014 | 55,47 | 56,18 | 55,47 | 55,75 | +0,74% | 1,29% | 6.821.642 |
| 21/07/2014 | 55,24 | 55,52 | 55,07 | 55,34 | -0,58% | 0,83% | 7.436.294 |
| 18/07/2014 | 55,27 | 55,75 | 54,98 | 55,67 | +1,28% | 1,40% | 7.789.470 |
| 17/07/2014 | 55,22 | 55,57 | 54,93 | 54,96 | -0,95% | 1,16% | 6.968.886 |
| 16/07/2014 | 55,29 | 55,54 | 55,09 | 55,49 | +0,41% | 0,83% | 7.131.640 |
| 15/07/2014 | 55,47 | 55,73 | 54,86 | 55,26 | -0,46% | 1,57% | 10.645.689 |
| 14/07/2014 | 55,94 | 55,98 | 55,40 | 55,52 | -0,44% | 1,04% | 8.781.297 |
| 11/07/2014 | 55,96 | 56,05 | 55,50 | 55,76 | -0,24% | 0,99% | 6.399.926 |
| 10/07/2014 | 55,61 | 56,08 | 55,09 | 55,90 | +0,05% | 1,78% | 5.851.718 |
| 09/07/2014 | 55,77 | 56,03 | 55,52 | 55,87 | +0,65% | 0,92% | 7.271.758 |
| 08/07/2014 | 55,97 | 55,98 | 55,26 | 55,51 | -0,60% | 1,30% | 8.667.065 |